Key statistics
As of last trade Viridian Therapeutics Inc (VRDN:NAQ) traded at 29.88, -12.86% below its 52-week high of 34.29, set on Jan 14, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 29.01 |
|---|---|
| High | 30.21 |
| Low | 28.20 |
| Bid | 29.83 |
| Offer | 29.93 |
| Previous close | 29.38 |
| Average volume | 1.46m |
|---|---|
| Shares outstanding | 102.21m |
| Free float | 91.96m |
| P/E (TTM) | -- |
| Market cap | 3.00bn USD |
| EPS (TTM) | -4.00 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 18:35 GMT.
More ▼
Events & Activity
- VRDN:NAQ reported earnings of -1.08 for the period of the year 2025Q4.
- VRDN:NAQ price moved over -6.32% to 27.11
- VRDN:NAQ price falls below 15-day moving average to 28.75 at 14:30 GMT
- VRDN:NAQ price falls below 15-day moving average to 28.83 at 15:06 GMT
- VRDN:NAQ price falls below 15-day moving average to 27.11 at 14:30 GMT
